Pedrosa Ana-Rita, Castillo-Kauil Alejandro, Kravchuk Yuliia, Reynolds Louise, Williams Bruce, Moore David, Lang Cameron, Allanki Srinivas, Maniati Eleni, Hardas Alexandros, Haj Jozafina, Drake Rebecca, Cleaver Julie, Foster Julie, Kim Jana, Stern Ester, Sosabowski Jane, Fruhwirth Gilbert O, Sahai Erik, Wald Ori, Hodivala-Dilke Kairbaan
Adhesion and Angiogenesis Lab, Centre for Tumour Microenvironment, John Vane Science Centre, Barts Cancer Institute, Queen Mary University, London, UK.
Department of Pathology, University of Cambridge, Cambridge, UK.
J Pathol. 2025 Jun 18. doi: 10.1002/path.6435.
Lung cancer is the leading cause of cancer-related death globally. To better understand the biology of lung cancer, mouse models have been developed using either tail vein-injected tumour cell lines or genetically modified mice. The current gold-standard models typically present with multiple lung foci. However, although these models are widely used, their correlation with human disease are limited, as early-stage human lung cancer usually presents as a single lesion rather than multiple foci. Additionally, a major challenge of using multifocal lung tumour models is the difficulty in distinguishing primary lung tumours from intrathoracic metastasis and lethal levels of lung congestion before distant metastases develop. Here, we present a refined and detailed surgical method in which murine tumour cells [Lewis lung carcinoma (LLC), alveogenic lung carcinoma (CMT), or Kras/Trp53-KP mutant cells] were injected directly into the left lung lobe of C57BL/6 mice, or, alternatively, adenoviral-Cre or adenoviral-FlpO was administered directly into the left lung lobe of Kras;Trp53 or Kras;Trp53 (KP) mice, respectively. This method generated unifocal primary left lung lobe tumours with traceable spread to local and distant sites. A cross-comparison of the unifocal models described commonalties and differences between LLC, CMT, KP cells, and adenoviral-Cre or -FlpO methods in terms of timings for primary lung tumour growth and traceable spread to local and distant sites, histological analysis of CD3 and CD11b immune cell infiltration, and Picrosirius Red analysis of extracellular matrix complexity. Lastly, the frequency of clinical histopathological features typical of human lung cancer were assessed across the unifocal mouse models to provide a direct comparison with human lung cancer. Overall, this study details a refined and reproducible protocol for intralobular lung injection to generate unifocal lung cancer models that resemble key features of human lung cancer. This approach can be applied to other lung cancer initiation strategies. The cross-comparative histological analysis across the models tested here offers a valuable resource to aid researchers in selecting the most appropriate next-generation unifocal lung cancer models for their specific research needs. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
肺癌是全球癌症相关死亡的主要原因。为了更好地理解肺癌生物学,人们利用尾静脉注射肿瘤细胞系或基因改造小鼠建立了小鼠模型。当前的金标准模型通常会出现多个肺病灶。然而,尽管这些模型被广泛使用,但它们与人类疾病的相关性有限,因为早期人类肺癌通常表现为单个病灶而非多个病灶。此外,使用多灶性肺肿瘤模型的一个主要挑战是,在远处转移发生之前,难以区分原发性肺肿瘤与胸内转移以及致死性肺充血水平。在此,我们介绍一种精细且详细的手术方法,即将鼠源肿瘤细胞[刘易斯肺癌(LLC)、肺泡源性肺癌(CMT)或Kras/Trp53-KP突变细胞]直接注射到C57BL/6小鼠的左肺叶,或者分别将腺病毒-Cre或腺病毒-FlpO直接注射到Kras;Trp53或Kras;Trp53(KP)小鼠的左肺叶。该方法产生了单灶性原发性左肺叶肿瘤,并伴有可追踪至局部和远处部位的扩散。对单灶性模型的交叉比较描述了LLC、CMT、KP细胞以及腺病毒-Cre或-FlpO方法在原发性肺肿瘤生长时间以及可追踪至局部和远处部位的扩散、CD3和CD11b免疫细胞浸润的组织学分析以及细胞外基质复杂性的天狼星红分析方面的共性和差异。最后,在单灶性小鼠模型中评估了人类肺癌典型临床组织病理学特征的频率,以便与人类肺癌进行直接比较。总体而言,本研究详细介绍了一种用于小叶内肺注射的精细且可重复的方案,以生成类似于人类肺癌关键特征的单灶性肺癌模型。这种方法可应用于其他肺癌起始策略。在此测试的各模型之间的交叉比较组织学分析为研究人员根据其特定研究需求选择最合适的下一代单灶性肺癌模型提供了宝贵资源。© 2025作者。《病理学杂志》由约翰·威利父子有限公司代表大不列颠及爱尔兰病理学会出版。